There is increasing support to categorize patients based on their ANCA serotype, i. e., PR3-ANCA and MPO-ANCA, as opposed to the traditional disease classification, i. e., GPA, MPA, and EGPA, as significant clinical differences exist between these two small-vessel vasculitides [7–17]. This evidence concerns the gene PRTN3 and microscopic polyangiitis.